Experimental vaccine takes on tough pancreatic cancer
NCT ID NCT07231094
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase trial will test a new tumor vaccine (SapDM275) combined with standard chemotherapy in 13 people with metastatic pancreatic cancer who have not had prior treatment. The vaccine aims to help the immune system attack cancer cells. The main goal is to check safety, but researchers will also look for signs of tumor shrinkage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SapDM275 tumor vaccine (targets MICA/B proteins) plus AG chemotherapy (nab-paclitaxel and gemcitabine)
- What this could lead to
- If it works, this could point toward a new treatment option for metastatic pancreatic cancer, potentially improving tumor shrinkage or delaying progression.
- What could go wrong
- This is a very early, small trial (13 people) focused on safety, not proof of effectiveness. The vaccine may not shrink tumors or could cause side effects. Many early-stage cancer vaccines fail in later testing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Third Xiangya Hospital of Central South University
Hunan, Changsha, 410000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug immune attack shrink Hard-to-Treat pancreatic tumors?
- Can three common drugs boost chemotherapy against pancreatic cancer?
- AI trained on thousands of pancreatic cancer cases could revolutionize diagnosis
- Smart drug delivers chemo directly to pancreatic cancer cells
- Gene-Guided chemo cocktail aims to tame tough pancreatic cancer
- New blood test could spot hidden cancer cells that spread